APA (7th ed.) Citation

KN, T., CR, L., L, G., KE, C., CM, F., A, G., . . . T, G. (2020). Clinical Pharmacogenetics Implementation Consortium Guideline (CPIC) for CYP2C9 and Nonsteroidal Anti-Inflammatory Drugs. Clinical pharmacology and therapeutics, 108(2), 191. https://doi.org/10.1002/cpt.1830

Chicago Style (17th ed.) Citation

KN, Theken, Lee CR, Gong L, Caudle KE, Formea CM, Gaedigk A, Klein TE, Agúndez JAG, and Grosser T. "Clinical Pharmacogenetics Implementation Consortium Guideline (CPIC) for CYP2C9 and Nonsteroidal Anti-Inflammatory Drugs." Clinical Pharmacology and Therapeutics 108, no. 2 (2020): 191. https://doi.org/10.1002/cpt.1830.

MLA (9th ed.) Citation

KN, Theken, et al. "Clinical Pharmacogenetics Implementation Consortium Guideline (CPIC) for CYP2C9 and Nonsteroidal Anti-Inflammatory Drugs." Clinical Pharmacology and Therapeutics, vol. 108, no. 2, 2020, p. 191, https://doi.org/10.1002/cpt.1830.